Indivior PLC Indivior Announces Upcoming Investor Events (3892G)
November 06 2018 - 2:00AM
UK Regulatory
TIDMINDV
RNS Number : 3892G
Indivior PLC
06 November 2018
Indivior Announces Upcoming Investor Events
Slough, UK, and Richmond, VA, 6 November 2018 - Indivior PLC
(LON: INDV) today announced the following upcoming investor
events:
Stifel 2018 Healthcare Conference, New York City:
On Tuesday, November 13th from 9:30 a.m. to 10:10 a.m. (local
time) Shaun Thaxter, CEO, and Mark Crossley, CFO, will conduct a
fireside chat with Max Hermann, Stifel Healthcare Analyst.
Indivior 2018 Capital Markets Day, New York City:
On Wednesday, December 5th from 9:00 a.m. to 12:30 p.m. (local
time), Indivior senior management will review and present the
Company's key business lines. Attendance for this event will
require pre-registration, as space is limited. To register, please
send an e-mail to jason.thompson@indivior.com.
A live webcast of both events, including any presentations, will
be available on the "Investors" section of the company's website at
www.indivior.com.
About Indivior
Indivior is a global specialty pharmaceutical company with a
20-year legacy of leadership in patient advocacy and health policy
while providing education on evidence-based treatment models that
have revolutionized modern addiction treatment. The name is the
fusion of the words individual and endeavor, and the tagline "Focus
on you" makes the Company's commitment clear. Indivior is dedicated
to transforming addiction from a global human crisis to a
recognized and treated chronic disease. Building on its global
portfolio of opioid dependence treatments, Indivior has a strong
pipeline of product candidates designed to both expand on its
heritage in this category and address other chronic conditions and
co-occurring disorders of addiction, including alcohol use disorder
and schizophrenia. Headquartered in the United States in Richmond,
VA, Indivior employs more than 900 individuals globally and its
portfolio of products is available in over 40 countries worldwide.
Visit www.indivior.com to learn more.
Contact:
Jason Thompson
Vice President, Investor Relations
Tel: 804-379-1033 or jason.thompson@indivior.com
###
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCZELFBVFFEFBD
(END) Dow Jones Newswires
November 06, 2018 02:00 ET (07:00 GMT)
Indivior (LSE:INDV)
Historical Stock Chart
From Apr 2024 to May 2024
Indivior (LSE:INDV)
Historical Stock Chart
From May 2023 to May 2024